Not exact matches
Furthermore, an early - stage study pumping up the dose
of its hemophilia A
treatment —
which aims to be a one - time therapy for the rare blood clotting - related disease — appeared to hit its targets without serious side
effects.
But researchers at the University
of Aberdeen found that a
treatment originally designed for fighting cancer and diabetes could melt away fatty arterial plaque with a single dosing and reverse the
effects of atherosclerosis,
which can lead to multiple heart problems.
CAR - T
treatments, including competing products from Novartis rivals Kite Pharma and Juno Therapeutics, come with the risk
of potentially deadly side
effects such as cytokine - release syndrome (CRS), in
which a glut
of T - cell - assisting cytokines can cause high fever, low blood pressure, and problems with lung oxygenation.
And herein lies a very broad and «mushy middle,» says McKenna, with the
effect, in many cases, being the same: «It's still using smaller - than -
treatment doses, or sub-therapeutic doses
of antibiotics,»
which creates a literal breeding ground for resistant microbial strains.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles
which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers
which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
People refusing medical
treatment because they think they can pray disease away, The demoralizing way religion makes you feel about yourself (I am a wretch, a sinner, a bad person by nature), the religious wars that have been fought for millenia, the self righteous passing laws based on THEIR beliefs (change to the pledge
of allegience
which now excludes anyone who does not believe in a fairy godfather, the change to the national motto that turned it into the lie «in god we trust», the bigotry that «my religion is the right one and you are wrong so I'll pray for you» kind
of crap... don't you realize that it is insulting to me when someone says they will pray for me... its the same as saying I'm going to do something for you but there won't be any
effect, so it is just a waste
of time.
The social problem
which has the most direct pernicious
effect on mental health is the inadequate provision
which our society makes for the
treatment of the major mental illnesses.
As Tiebout pointed out, the direct
treatment of the alcoholic's «runaway symptom» is essential, and it consists
of methods by
which the cycle
of drinking to overcome the
effects of previous drinking is blocked.
Much contemporary
treatment of history has put just such an emphasis on anamnesis; much is said about the vital entrance
of the historian into the past, a participation
which has the
effect of making that past come alive again in the present.
Further, buckwheat is the richest food source
of D - chiro - inositol,
which is known for its glucose - lowering
effects and benefits for the
treatment of diabetes.
After the patient has returned home from the hospital, the next stage
of treatment is consolidation, in
which patients receive several additional rounds
of chemotherapy to build upon the
effects of induction.
A large number
of ovaries increases the chance
of pregnancy, but unfortunately has also been associated with ovarian hyperstimulation syndrome (OHSS),
which is sometimes called the most important side
effect of fertility
treatment.
We examined plots visually to see whether there was any evidence
of asymmetry that might suggest different
treatment effects in smaller studies,
which may indicate publication bias (Harbord 2006).
Treatment with the use
of medical cannabis also has shown adverse
effects such as daytime sleepiness,
which may lead to unintended consequences such as motor vehicle accidents.
«We hope that interventions to decrease macrophage activation early in HIV infection will decrease associated bone loss,
which has become a major adverse side
effect of HIV infection and its
treatment,» Aldrovandi said.
Their results raise new possibilities for the management
of diarrhea,
which is often a side
effect of melanoma
treatment.
For men with intermediate risk prostate cancer, side
effects at two years following radiation therapy (RT) were comparable for extremely - hypofractionated
treatment,
which was delivered in seven fractions across two and a half weeks, and conventional
treatment of 39 fractions across eight weeks, according to research presented at the 58th Annual Meeting
of the American Society for Radiation Oncology (ASTRO).
No major toxic
effects were observed, and the patient «was able to survive a much longer period than expected with an improved quality
of life,
which is clearly attributable to the
treatment with 3BP,» the scientists concluded.
Cochran says the only side
effect was mild bleeding in one
of the six,
which stopped when tPA
treatment was also halted.
Ms Koechlin, Professor Philippe Autier and colleagues used statistical models to work out whether current cancer death rates were due more to the
effects of age, the year
of birth (
which takes into account exposure to cancer - causing agents such as sunshine during early life), or to the recent introduction
of new medical technologies or
treatments.
At most centers,
treatment for inflammatory bowel disease (IBD) is limited and usually takes patients down one
of two routes: steroids or medication,
which can often lead to life - long side
effects.
«Once we understand how the brain systems producing the positive / euphoric and negative / anxiety
effects of the drug interact, we might be able to produce
treatments that address the balance between these two opposing actions, both
of which serve as strong driving forces.
The researchers gave rats with liver cancer either the LDL - DHA nanoparticles or control
treatments of LDL without DHA,
which were expected to have no
effect.
With support from pharma, we can refine these molecules over the next 10 - 20 years to develop anti-aging
treatments which don't have the adverse
effects of cancer drugs.»
Since neither the patients nor the researchers knew
which treatment each person actually received, the true
effect of the LFMS could be measured.
It is possible that medical advances over the past few decades in the
treatment of type 2 diabetes, hypertension and high cholesterol levels have had a greater impact on people who are overweight —
which increases the risk for these conditions — whereas the
effect was much smaller in those
of normal weight.
«New soft material could reduce complications for women suffering from urinary incontinence: Researchers have developed a novel implantable material
which could reduce the number
of debilitating side -
effects that occur as a result
of using a material that is too rigid for surgical
treatment of incontinence.»
Furthermore, the report accuses the British Homeopathic Association (BHA),
which had submitted evidence to the panel,
of cherry - picking, and even, in one case actively misrepresenting, research into the
treatment (a famous study that concluded its findings were «compatible with the notion that the clinical
effects of homeopathy are placebo
effects» was cited by the BHA as evidence
of the
treatment's efficacy.)
Researchers at the University
of Sheffield have developed a novel implantable material
which could reduce the number
of debilitating side -
effects that occur as a result
of using a material that is too rigid for surgical
treatment of incontinence.
According to Dr. Rosamilia, early
treatment not only can reduce the pain and severity
of the disease, but also can help prevent potential side
effects like eye problems, infection, and a condition called post-herpetic neuralgia,
which causes pain, numbness, itching and tingling.
«Our collaboration with scientists at Charles Gerhardt Institute was important to the success
of this two - photon activated technique,» said Tamanoi, «
which provides controls over drug delivery to allow local
treatment that dramatically reduces side
effects.»
However, if SSRIs had indeed acted merely by means
of a placebo
effect, these drugs should not outperform actual placebo in clinical trials where patients have been treated with an SSRI or with ineffective placebo pills, and where neither the physician nor the patient knows
which treatment the patient has been given until the study is over.
«A potential reason might be related to the
effects of treatment, such as menopausal symptoms and lymphodoema,
which might contribute to emotional distress.
«We would give this biologic —
which has minimal side
effects — to any patient we identify through a blood test as producing HE4,» he says, adding that oncologists have recognized that women with high levels
of HE4 do not respond to
treatment and their survival rates are lower.
Rokers says showing the
effects of teaching people to use cues to three - dimensional motion that they are otherwise ignoring may ultimately help refine
treatment for vision disorders such as blind spots or amblyopia («lazy eye») in
which the brain can be trained to compensate for perceptual limitations.
«The advantage an optogentic approach has over other immunotherapies,
which typically activate global immune responses, is that we now have the tools to closely monitor the dose and location
of the
treatment to mitigate potential side
effects to healthy tissues.»
For most available T cell immunotherapies, T cells (
which play a central role in defending the body against illness) are engineered to recognize and eliminate tumors, but their activity is not specifically controlled, leading to toxicity and unwanted side
effects in patients as a result
of inflammation or in some cases suboptimal response to
treatment.
The research,
which appears in the journal The Lancet Oncology, should aid efforts to reduce and better manage the late
effects of cancer
treatment.
«Yet many cancer survivors are living with difficult and persistent side
effects of these
treatments,
which can be incapacitating.
According to researchers, antibiotic resistance and side
effects limit the efficacy
of the current
treatments,
which include benzoyl peroxide, retinoids, antibiotics and Accutane (isotretinonin).
This enabled us to examine whether the possible
effects of rapamycin depend on the age at
which treatment started.»
The study is investigator led and has therefore focused on clinical need, targeting patients with progressive multiple sclerosis in whom most disability is incurred... The study also reports a predominant
effect on neurodegenerative rather than inflammatory outcomes, suggesting a novel mechanism
of action that might be suitable as combination
treatment with immunomodulatory
treatments... Further phase 3 studies to measure the
effect of simvastatin on sustained disability, particularly in patients with non-relapsing secondary progressive and primary progressive multiple sclerosis, are clearly needed, but this trial represents a promising point from
which to develop trials
of progressive disease.»
If, for example, the crucial
effects of neutrinos were included in some detailed
treatment, the computer simulations could only be performed in two dimensions,
which means that the star in the models was assumed to have an artificial rotational symmetry around an axis.
Lithium
treatment was associated with less thinning
of gray matter,
which suggests a protective
effect of this medication on the brain.
The diagnosis and
treatment of female cancers are known to affect fertility for several reasons: some chemotherapy regimens can cause damage to the ovary, and this can occur at any age; radiotherapy can also compromise female fertility through
effects on the ovary, uterus and potentially those brain centres
which control the reproductive axis.
The researchers believe that their software has the potential to help doctors to identify
which of those patients are at low risk
of suffering side
effects and hence might benefit from
treatment.
However, this study indicates that not all at risk patients show accelerated lung function decline,
which may explain why, so far, the
effect of various
treatments of lung function decline has been difficult to establish.
«Identifying a cancer driver is crucial for cancer
treatment because it allows the use
of targeted therapies,
which have less side -
effects than conventional chemotherapy drugs, against a particular protein,» said Kurokawa.
Currently available
treatments have only modest
effects on the disease and its symptoms,
which underlines the importance
of identifying preventive measures.
Professor Sadler comments that this research could lead to new cancer
treatments: «Cancer drugs with new mechanisms
of actions
which can combat resistance and have fewer side -
effects are urgently needed.